Lgals3bp Rat (-)-epigallocatechin 3-gallate multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LGALS3BP mRNA CTD PMID:22079256 Lgals3bp Rat (R,R,R)-alpha-tocopherol multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of LGALS3BP protein CTD PMID:36372912 Lgals3bp Rat 1,1-dichloroethene increases expression ISO Lgals3bp (Mus musculus) 6480464 vinylidene chloride results in increased expression of LGALS3BP mRNA CTD PMID:26682919 Lgals3bp Rat 1,2-dimethylhydrazine multiple interactions ISO Lgals3bp (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LGALS3BP mRNA CTD PMID:22206623 Lgals3bp Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of LGALS3BP mRNA CTD PMID:17557909 Lgals3bp Rat 17beta-estradiol multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LGALS3BP mRNA CTD PMID:19619570 Lgals3bp Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of LGALS3BP mRNA CTD PMID:32145629 and PMID:35192832 Lgals3bp Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGALS3BP mRNA CTD PMID:32741896 Lgals3bp Rat 17beta-estradiol increases expression ISO Lgals3bp (Mus musculus) 6480464 Estradiol results in increased expression of LGALS3BP mRNA CTD PMID:15289156 and PMID:19484750 Lgals3bp Rat 17beta-estradiol increases expression ISO LGALS3BP (Homo sapiens) 6480464 Estradiol results in increased expression of LGALS3BP mRNA CTD PMID:19619570 and PMID:21185374 Lgals3bp Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of LGALS3BP mRNA CTD PMID:20068009 Lgals3bp Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGALS3BP mRNA CTD PMID:32741896 Lgals3bp Rat 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Lgals3bp (Mus musculus) 6480464 2 more ... CTD PMID:30294300 Lgals3bp Rat 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 Lgals3bp Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LGALS3BP mRNA CTD PMID:19619570 Lgals3bp Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3BP mRNA CTD PMID:34747641 Lgals3bp Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Lgals3bp (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LGALS3BP mRNA CTD PMID:33956508 Lgals3bp Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lgals3bp (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3BP mRNA CTD PMID:21570461 Lgals3bp Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3BP mRNA CTD PMID:21215274 Lgals3bp Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO LGALS3BP (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3BP mRNA CTD PMID:19619570 Lgals3bp Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of LGALS3BP protein CTD PMID:34915118 Lgals3bp Rat 4,4'-diaminodiphenylmethane increases expression ISO Lgals3bp (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of LGALS3BP mRNA CTD PMID:18648102 Lgals3bp Rat 4,4'-sulfonyldiphenol increases expression ISO Lgals3bp (Mus musculus) 6480464 bisphenol S results in increased expression of LGALS3BP mRNA CTD PMID:30951980 Lgals3bp Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LGALS3BP mRNA CTD PMID:36041667 Lgals3bp Rat 4,4'-sulfonyldiphenol increases expression ISO LGALS3BP (Homo sapiens) 6480464 bisphenol S results in increased expression of LGALS3BP protein CTD PMID:34186270 Lgals3bp Rat 5-fluorouracil affects response to substance ISO LGALS3BP (Homo sapiens) 6480464 LGALS3BP protein affects the susceptibility to Fluorouracil CTD PMID:16217747 Lgals3bp Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LGALS3BP mRNA CTD PMID:24780913 Lgals3bp Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of LGALS3BP mRNA CTD PMID:36843608 Lgals3bp Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of LGALS3BP mRNA CTD PMID:31881176 Lgals3bp Rat acrolein multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LGALS3BP mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LGALS3BP mRNA CTD PMID:32699268 Lgals3bp Rat acrylamide affects expression EXP 6480464 Acrylamide affects the expression of LGALS3BP mRNA CTD PMID:28959563 Lgals3bp Rat acrylamide decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Acrylamide results in decreased expression of LGALS3BP mRNA CTD PMID:32763439 Lgals3bp Rat aflatoxin B1 decreases expression ISO Lgals3bp (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of LGALS3BP mRNA CTD PMID:19770486 Lgals3bp Rat aflatoxin B1 decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of LGALS3BP mRNA CTD PMID:27153756 Lgals3bp Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LGALS3BP mRNA CTD PMID:22484513 more ... Lgals3bp Rat aldehydo-D-glucose multiple interactions ISO Lgals3bp (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LGALS3BP mRNA CTD PMID:37567420 Lgals3bp Rat all-trans-retinoic acid multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of LGALS3BP mRNA CTD PMID:15894607 Lgals3bp Rat all-trans-retinoic acid increases expression ISO LGALS3BP (Homo sapiens) 6480464 Tretinoin results in increased expression of LGALS3BP mRNA CTD PMID:15894607 more ... Lgals3bp Rat alpha-pinene multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LGALS3BP mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LGALS3BP mRNA CTD PMID:32699268 Lgals3bp Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LGALS3BP mRNA CTD PMID:16483693 Lgals3bp Rat antirheumatic drug decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of LGALS3BP mRNA CTD PMID:24449571 Lgals3bp Rat aristolochic acid A decreases expression ISO LGALS3BP (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of LGALS3BP protein CTD PMID:33212167 Lgals3bp Rat arsenous acid increases expression ISO LGALS3BP (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LGALS3BP protein CTD PMID:25419056 Lgals3bp Rat arsenous acid multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LGALS3BP mRNA CTD PMID:15894607 Lgals3bp Rat atrazine decreases expression ISO Lgals3bp (Mus musculus) 6480464 Atrazine results in decreased expression of LGALS3BP mRNA CTD PMID:27655631 Lgals3bp Rat benzo[a]pyrene decreases expression ISO Lgals3bp (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of LGALS3BP mRNA CTD PMID:19770486 Lgals3bp Rat benzo[a]pyrene increases methylation ISO LGALS3BP (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of LGALS3BP exon and Benzo(a)pyrene results in increased methylation of LGALS3BP promoter CTD PMID:27901495 Lgals3bp Rat benzo[a]pyrene increases expression ISO Lgals3bp (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of LGALS3BP mRNA CTD PMID:23735875 Lgals3bp Rat beta-lapachone increases expression ISO LGALS3BP (Homo sapiens) 6480464 beta-lapachone results in increased expression of LGALS3BP mRNA CTD PMID:38218311 Lgals3bp Rat beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LGALS3BP mRNA CTD PMID:18164116 Lgals3bp Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LGALS3BP mRNA CTD PMID:25181051 and PMID:32145629 Lgals3bp Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LGALS3BP mRNA CTD PMID:36041667 Lgals3bp Rat bisphenol A increases expression ISO Lgals3bp (Mus musculus) 6480464 bisphenol A results in increased expression of LGALS3BP mRNA CTD PMID:34585602 Lgals3bp Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LGALS3BP mRNA CTD PMID:34947998 Lgals3bp Rat bisphenol A decreases expression ISO Lgals3bp (Mus musculus) 6480464 bisphenol A results in decreased expression of LGALS3BP mRNA CTD PMID:33221593 Lgals3bp Rat bisphenol A affects expression ISO LGALS3BP (Homo sapiens) 6480464 bisphenol A affects the expression of LGALS3BP mRNA CTD PMID:30903817 Lgals3bp Rat bisphenol A increases expression ISO LGALS3BP (Homo sapiens) 6480464 bisphenol A results in increased expression of LGALS3BP mRNA and bisphenol A results in increased expression of LGALS3BP protein CTD PMID:29275510 and PMID:37567409 Lgals3bp Rat bisphenol A increases methylation ISO Lgals3bp (Mus musculus) 6480464 bisphenol A results in increased methylation of LGALS3BP promoter CTD PMID:27312807 Lgals3bp Rat Bisphenol B increases expression ISO LGALS3BP (Homo sapiens) 6480464 bisphenol B results in increased expression of LGALS3BP protein CTD PMID:34186270 Lgals3bp Rat bisphenol F increases expression ISO Lgals3bp (Mus musculus) 6480464 bisphenol F results in increased expression of LGALS3BP mRNA CTD PMID:30951980 Lgals3bp Rat bisphenol F increases expression ISO LGALS3BP (Homo sapiens) 6480464 bisphenol F results in increased expression of LGALS3BP protein CTD PMID:34186270 Lgals3bp Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LGALS3BP mRNA CTD PMID:36041667 Lgals3bp Rat butan-1-ol multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of LGALS3BP mRNA CTD PMID:29432896 Lgals3bp Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of LGALS3BP mRNA CTD PMID:25993096 Lgals3bp Rat carbon nanotube increases expression ISO Lgals3bp (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Lgals3bp Rat carnosic acid decreases expression ISO Lgals3bp (Mus musculus) 6480464 salvin results in decreased expression of LGALS3BP protein CTD PMID:35926579 Lgals3bp Rat choline multiple interactions ISO Lgals3bp (Mus musculus) 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of LGALS3BP mRNA and PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of LGALS3BP mRNA] CTD PMID:29246445 Lgals3bp Rat ciprofibrate increases expression ISO Lgals3bp (Mus musculus) 6480464 ciprofibrate results in increased expression of LGALS3BP mRNA CTD PMID:12771043 Lgals3bp Rat cisplatin multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of LGALS3BP mRNA and [Piroxicam co-treated with Cisplatin] results in decreased expression of LGALS3BP mRNA CTD PMID:21858171 and PMID:27392435 Lgals3bp Rat cisplatin increases expression ISO LGALS3BP (Homo sapiens) 6480464 Cisplatin results in increased expression of LGALS3BP mRNA CTD PMID:27392435 Lgals3bp Rat cisplatin increases expression ISO Lgals3bp (Mus musculus) 6480464 Cisplatin results in increased expression of LGALS3BP mRNA CTD PMID:21151649 Lgals3bp Rat copper(II) chloride decreases expression ISO LGALS3BP (Homo sapiens) 6480464 cupric chloride results in decreased expression of LGALS3BP mRNA CTD PMID:38568856 Lgals3bp Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of LGALS3BP mRNA CTD PMID:26577399 and PMID:27523638 Lgals3bp Rat cyclosporin A decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Cyclosporine results in decreased expression of LGALS3BP mRNA CTD PMID:20106945 and PMID:25562108 Lgals3bp Rat D-glucose multiple interactions ISO Lgals3bp (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LGALS3BP mRNA CTD PMID:37567420 Lgals3bp Rat deoxynivalenol decreases expression ISO LGALS3BP (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of LGALS3BP protein CTD PMID:33890134 Lgals3bp Rat diarsenic trioxide multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LGALS3BP mRNA CTD PMID:15894607 Lgals3bp Rat diarsenic trioxide increases expression ISO LGALS3BP (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LGALS3BP protein CTD PMID:25419056 Lgals3bp Rat diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of LGALS3BP mRNA CTD PMID:21161181 Lgals3bp Rat diethylstilbestrol increases expression ISO Lgals3bp (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of LGALS3BP mRNA CTD PMID:15289156 Lgals3bp Rat dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LGALS3BP mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LGALS3BP mRNA CTD PMID:33729688 Lgals3bp Rat dorsomorphin multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LGALS3BP mRNA CTD PMID:27188386 Lgals3bp Rat doxorubicin decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Doxorubicin results in decreased expression of LGALS3BP mRNA CTD PMID:29803840 Lgals3bp Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of LGALS3BP mRNA CTD PMID:29391264 Lgals3bp Rat enzyme inhibitor multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LGALS3BP protein CTD PMID:23301498 Lgals3bp Rat epoxiconazole decreases expression ISO Lgals3bp (Mus musculus) 6480464 epoxiconazole results in decreased expression of LGALS3BP mRNA CTD PMID:35436446 Lgals3bp Rat ethanol increases expression ISO Lgals3bp (Mus musculus) 6480464 Ethanol results in increased expression of LGALS3BP mRNA CTD PMID:30319688 Lgals3bp Rat fenthion increases expression ISO Lgals3bp (Mus musculus) 6480464 Fenthion results in increased expression of LGALS3BP mRNA CTD PMID:34813904 Lgals3bp Rat folic acid decreases expression ISO Lgals3bp (Mus musculus) 6480464 Folic Acid results in decreased expression of LGALS3BP mRNA CTD PMID:25629700 Lgals3bp Rat folic acid multiple interactions ISO Lgals3bp (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LGALS3BP mRNA CTD PMID:22206623 Lgals3bp Rat fructose multiple interactions ISO Lgals3bp (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LGALS3BP mRNA CTD PMID:37567420 Lgals3bp Rat furan increases expression EXP 6480464 furan results in increased expression of LGALS3BP mRNA CTD PMID:27387713 Lgals3bp Rat genistein increases expression ISO Lgals3bp (Mus musculus) 6480464 Genistein results in increased expression of LGALS3BP mRNA CTD PMID:15289156 Lgals3bp Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LGALS3BP mRNA CTD PMID:22061828 Lgals3bp Rat glucose multiple interactions ISO Lgals3bp (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LGALS3BP mRNA CTD PMID:37567420 Lgals3bp Rat glycerol multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of LGALS3BP protein and [hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of LGALS3BP protein CTD PMID:36372912 Lgals3bp Rat glycidol decreases expression EXP 6480464 glycidol results in decreased expression of LGALS3BP mRNA CTD PMID:24395379 Lgals3bp Rat glyphosate multiple interactions ISO Lgals3bp (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of LGALS3BP mRNA CTD PMID:37567420 Lgals3bp Rat ivermectin decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Ivermectin results in decreased expression of LGALS3BP protein CTD PMID:32959892 Lgals3bp Rat ketamine increases expression EXP 6480464 Ketamine results in increased expression of LGALS3BP mRNA CTD PMID:20080153 Lgals3bp Rat lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of LGALS3BP mRNA CTD PMID:35283115 Lgals3bp Rat lipopolysaccharide decreases expression ISO Lgals3bp (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of LGALS3BP mRNA CTD PMID:21461237 Lgals3bp Rat lipopolysaccharide increases expression ISO LGALS3BP (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of LGALS3BP protein CTD PMID:30501627 Lgals3bp Rat lipopolysaccharide increases expression ISO Lgals3bp (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of LGALS3BP mRNA CTD PMID:27339419 Lgals3bp Rat methidathion increases expression ISO Lgals3bp (Mus musculus) 6480464 methidathion results in increased expression of LGALS3BP mRNA CTD PMID:34813904 Lgals3bp Rat methylphenidate decreases expression ISO Lgals3bp (Mus musculus) 6480464 Methylphenidate results in decreased expression of LGALS3BP mRNA CTD PMID:22470460 Lgals3bp Rat microcystin-LR increases expression ISO Lgals3bp (Mus musculus) 6480464 cyanoginosin LR results in increased expression of LGALS3BP mRNA CTD PMID:17654400 Lgals3bp Rat N-methyl-4-phenylpyridinium increases expression ISO LGALS3BP (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of LGALS3BP mRNA CTD PMID:24810058 Lgals3bp Rat N-nitrosodiethylamine increases expression ISO Lgals3bp (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of LGALS3BP mRNA CTD PMID:12771043 Lgals3bp Rat N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of LGALS3BP mRNA CTD PMID:19638242 Lgals3bp Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LGALS3BP mRNA and [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3BP mRNA CTD PMID:18164116 and PMID:28943392 Lgals3bp Rat N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of LGALS3BP mRNA CTD PMID:19716841 Lgals3bp Rat ozone multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LGALS3BP mRNA more ... CTD PMID:32699268 Lgals3bp Rat paracetamol affects expression ISO Lgals3bp (Mus musculus) 6480464 Acetaminophen affects the expression of LGALS3BP mRNA CTD PMID:17562736 Lgals3bp Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LGALS3BP mRNA CTD PMID:33387578 Lgals3bp Rat paracetamol decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Acetaminophen results in decreased expression of LGALS3BP mRNA CTD PMID:29067470 Lgals3bp Rat PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 Lgals3bp Rat pentachlorophenol increases expression ISO Lgals3bp (Mus musculus) 6480464 Pentachlorophenol results in increased expression of LGALS3BP mRNA CTD PMID:23892564 Lgals3bp Rat perfluorooctanoic acid decreases expression ISO LGALS3BP (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of LGALS3BP protein CTD PMID:26879310 Lgals3bp Rat phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of LGALS3BP mRNA CTD PMID:19162173 Lgals3bp Rat phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of LGALS3BP mRNA CTD PMID:18158353 Lgals3bp Rat pirinixic acid increases expression ISO Lgals3bp (Mus musculus) 6480464 pirinixic acid results in increased expression of LGALS3BP mRNA CTD PMID:23811191 Lgals3bp Rat piroxicam multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of LGALS3BP mRNA CTD PMID:21858171 Lgals3bp Rat potassium chromate increases expression ISO LGALS3BP (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of LGALS3BP mRNA CTD PMID:22079256 Lgals3bp Rat potassium chromate multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LGALS3BP mRNA CTD PMID:22079256 Lgals3bp Rat propane-1,2-diol multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of LGALS3BP protein and [hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of LGALS3BP protein CTD PMID:36372912 Lgals3bp Rat quercetin decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Quercetin results in decreased expression of LGALS3BP mRNA CTD PMID:15309432 Lgals3bp Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of LGALS3BP mRNA CTD PMID:28374803 Lgals3bp Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of LGALS3BP protein CTD PMID:35544339 Lgals3bp Rat SB 431542 multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LGALS3BP mRNA CTD PMID:27188386 Lgals3bp Rat silicon dioxide affects secretion ISO LGALS3BP (Homo sapiens) 6480464 Silicon Dioxide analog affects the secretion of LGALS3BP protein CTD PMID:25895662 Lgals3bp Rat silver atom affects expression ISO Lgals3bp (Mus musculus) 6480464 Silver affects the expression of LGALS3BP mRNA CTD PMID:27131904 Lgals3bp Rat silver(0) affects expression ISO Lgals3bp (Mus musculus) 6480464 Silver affects the expression of LGALS3BP mRNA CTD PMID:27131904 Lgals3bp Rat sodium arsenite multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 sodium arsenite results in decreased expression of and affects the splicing of LGALS3BP mRNA CTD PMID:25879800 Lgals3bp Rat sodium arsenite decreases expression ISO LGALS3BP (Homo sapiens) 6480464 sodium arsenite results in decreased expression of LGALS3BP mRNA CTD PMID:38568856 Lgals3bp Rat sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of LGALS3BP mRNA CTD PMID:25993096 Lgals3bp Rat sodium fluoride decreases expression ISO Lgals3bp (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of LGALS3BP protein CTD PMID:28918527 Lgals3bp Rat Soman increases expression EXP 6480464 Soman results in increased expression of LGALS3BP mRNA CTD PMID:19281266 Lgals3bp Rat sulindac multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3BP mRNA] CTD PMID:15190207 Lgals3bp Rat sunitinib decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Sunitinib results in decreased expression of LGALS3BP mRNA CTD PMID:31533062 Lgals3bp Rat tamoxifen increases expression ISO LGALS3BP (Homo sapiens) 6480464 Tamoxifen results in increased expression of LGALS3BP mRNA CTD PMID:19155303 Lgals3bp Rat tamoxifen affects expression ISO Lgals3bp (Mus musculus) 6480464 Tamoxifen affects the expression of LGALS3BP mRNA CTD PMID:20937368 Lgals3bp Rat temozolomide increases expression ISO LGALS3BP (Homo sapiens) 6480464 Temozolomide results in increased expression of LGALS3BP mRNA CTD PMID:31758290 Lgals3bp Rat tert-butyl hydroperoxide increases expression ISO Lgals3bp (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of LGALS3BP mRNA CTD PMID:14729362 Lgals3bp Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LGALS3BP mRNA CTD PMID:32741896 Lgals3bp Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LGALS3BP mRNA CTD PMID:16239168 Lgals3bp Rat tetrachloromethane increases expression ISO Lgals3bp (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of LGALS3BP mRNA CTD PMID:31919559 Lgals3bp Rat thimerosal decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Thimerosal results in decreased expression of LGALS3BP mRNA CTD PMID:27188386 Lgals3bp Rat thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3BP mRNA CTD PMID:28943392 Lgals3bp Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LGALS3BP mRNA CTD PMID:34492290 Lgals3bp Rat thiram decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Thiram results in decreased expression of LGALS3BP mRNA CTD PMID:38568856 Lgals3bp Rat titanium dioxide increases expression ISO Lgals3bp (Mus musculus) 6480464 titanium dioxide results in increased expression of LGALS3BP mRNA CTD PMID:23557971 and PMID:27760801 Lgals3bp Rat triclosan increases expression ISO LGALS3BP (Homo sapiens) 6480464 Triclosan results in increased expression of LGALS3BP mRNA CTD PMID:30510588 Lgals3bp Rat triptonide increases expression ISO Lgals3bp (Mus musculus) 6480464 triptonide results in increased expression of LGALS3BP mRNA CTD PMID:33045310 Lgals3bp Rat tunicamycin decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Tunicamycin results in decreased expression of LGALS3BP mRNA CTD PMID:22378314 Lgals3bp Rat valproic acid affects expression ISO Lgals3bp (Mus musculus) 6480464 Valproic Acid affects the expression of LGALS3BP mRNA CTD PMID:17292431 Lgals3bp Rat valproic acid multiple interactions ISO LGALS3BP (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LGALS3BP mRNA CTD PMID:27188386 Lgals3bp Rat valproic acid decreases expression ISO LGALS3BP (Homo sapiens) 6480464 Valproic Acid results in decreased expression of LGALS3BP mRNA CTD PMID:23179753 more ... Lgals3bp Rat valproic acid affects expression ISO LGALS3BP (Homo sapiens) 6480464 Valproic Acid affects the expression of LGALS3BP mRNA CTD PMID:25979313 Lgals3bp Rat valproic acid increases methylation ISO LGALS3BP (Homo sapiens) 6480464 Valproic Acid results in increased methylation of LGALS3BP gene CTD PMID:29154799 Lgals3bp Rat vancomycin decreases expression ISO Lgals3bp (Mus musculus) 6480464 Vancomycin results in decreased expression of LGALS3BP mRNA CTD PMID:18930951 Lgals3bp Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of LGALS3BP mRNA CTD PMID:22570695 Lgals3bp Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of LGALS3BP mRNA CTD PMID:19015723 Lgals3bp Rat vorinostat decreases expression ISO LGALS3BP (Homo sapiens) 6480464 vorinostat results in decreased expression of LGALS3BP mRNA CTD PMID:27188386